Si-Rui Ma

university of california san francisco

H指数:24

被引数:2,249

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Response to “Methodological considerations in assessing bleeding risk during therapeutic plasma exchange”

对“评估治疗性血浆置换期间出血风险的方法学考量”的回应

Transfusion

IF2

2025-10-130

PRE

Comparison of anticoagulants and risk of ischemic stroke in patients with acute cancer-associated venous thromboembolism

抗凝剂与急性癌症相关静脉血栓栓塞症患者缺血性卒中的风险比较

Blood Advances

IF7.1

2025-08-250

OAAI

Hemostatic and thrombotic outcomes in patients undergoing therapeutic plasma exchange

行治疗性血浆置换患者的止血和血栓形成结局

Transfusion

IF2

2025-06-250

PRE

A biomimetic solution, albumin-doxorubicin molecular complex, targeting tumor and tumor-draining lymph nodes

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2024-01-010

PRE

One case of sublingual gland mucosa-associated lymphoid tissue lymphoma

ORAL ONCOLOGY

IF3.9

2024-01-011

PRE

Influence of thrombocytopenia on bleeding and vascular events in atrial fibrillation

BLOOD ADVANCES

IF7.1

2023-12-158

OAAI

Red Blood Cell-Derived Extracellular Vesicles: An Overview of Current Research Progress, Challenges, and Opportunities

BIOMEDICINES

IF3.9

2023-10-167

OAAI

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma

BIOMEDICINES

IF3.9

2023-10-060

OAAI

Targeting the lipid metabolic reprogramming of tumor-associated macrophages: A novel insight into cancer immunotherapy

靶向肿瘤相关巨噬细胞的脂质代谢重编程: 癌症免疫治疗的新见解

CELLULAR ONCOLOGY

IF4.8

2023-09-304

PRE

Antiplatelet medications and intracranial hemorrhage in patients with primary brain tumors

JOURNAL OF THROMBOSIS AND HAEMOSTASIS

IF5

2023-05-015

OAAI

Salvage therapies for radiation-relapsed isocitrate dehydrogenase-mutant astrocytoma and 1p/19q codeleted oligodendroglioma

NEURO-ONCOLOGY ADVANCES

IF4.1

2021-06-180

OAAI

Evaluation of interim MRI changes during limited-field radiation therapy for glioblastoma and implications for treatment planning

RADIOTHERAPY AND ONCOLOGY

IF5.3

2021-05-017

OAAI

Prognostic impact of CDKN2A/B deletion, TERT mutation, and EGFR amplification on histological and molecular IDH-wildtype glioblastoma

CDKN2A/B缺失，TERT突变和EGFR扩增对组织学和分子IDH野生型胶质母细胞瘤的预后影响

NEURO-ONCOLOGY ADVANCES

IF4.1

2020-09-180

OAAI

Evaluation of a Multi-Modal Radiation Oncology Elective for First-Year Medical Students

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-09-010

PREAI

Prognostic Impact of Telomerase Reverse Transcriptase Mutation and O6-Methylguanine-DNA Methyltransferase Methylation in Isocitrate Dehydrogenase Wild-type Glioblastoma

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

IF6.5

2019-04-010

OAAI

Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients

JOURNAL OF NEURO-ONCOLOGY

IF3.1

2019-03-1234

PREAI

Specific blockade CD73 alters the exhausted phenotype of T cells in head and neck squamous cell carcinoma

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2018-08-0837

OAAI

Anti-CD47 treatment enhances anti-tumor T-cell immunity and improves immunosuppressive environment in head and neck squamous cell carcinoma

ONCOIMMUNOLOGY

IF6.3

2018-03-1352

OAAI

Inhibition of JAK2/STAT3 reduces tumor-induced angiogenesis and myeloid-derived suppressor cells in head and neck cancer

MOLECULAR CARCINOGENESIS

IF3.2

2017-12-3068

PREAI

Blockade of adenosine A2A receptor enhances CD8+ T cells response and decreases regulatory T cells in head and neck squamous cell carcinoma

阻断腺苷A2A受体可增强头颈部鳞状细胞癌中CD8 T细胞的反应并减少调节性T细胞

MOLECULAR CANCER

IF33.9

2017-06-07153

OAAI

Si-Rui Ma

个人简介

教育背景

工作经历

荣誉奖项

研究方向